A global study to assess the efficacy and tolerability of rilvegostomig compared toplacebo in combination with investigator's choice of chemotherapy in participants withBTC after surgical resection with curative intent.
A Phase III, Randomized, Double-Blind, Placebo-Controlled,
Multicenter, Global Study of Rilvegostomig in Combination With
Chemotherapy as Adjuvant Treatment After Resection of Biliary
Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)
